Unusually prolonged rebound cataplexy after withdrawal of fluoxetine.
Poryazova
Rositsa
R
Neurology Department, University Hospital, Zurich, Switzerland.
Siccoli
Massimiliano
M
Werth
Esther
E
Bassetti
Claudio L
CL
D001933:Brain Stem / Q000187:drug effects / Q000503:physiopathology; D002385:Cataplexy / Q000139:chemically induced* / Q000503:physiopathology*; D004569:Electroencephalography / Q000187:drug effects; D004576:Electromyography; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009123:Muscle Hypotonia / Q000139:chemically induced / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000294:innervation / Q000503:physiopathology; D009290:Narcolepsy / Q000188:drug therapy* / Q000503:physiopathology; D017286:Polysomnography; D020923:REM Sleep Parasomnias / Q000139:chemically induced / Q000503:physiopathology; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D013997:Time Factors
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors